Scott D. Myers is a businessperson who has been at the helm of 8 different companies. Presently, he holds the position of Chairman for Dynavax Technologies Corp., Chairman of Highland Therapeutics, Inc., Chairman for Sensorion SAS and Chairman of Harpoon Therapeutics, Inc.
He is also on the board of Selecta Biosciences, Inc.
In his past career Scott D. Myers was Chairman & Chief Executive Officer at Rainier Therapeutics, Inc., Vice President for UCB SA, President, CEO & Head-Media Contact at Aerocrine AB, President, Chief Executive Officer & Director at Cascadian Therapeutics LLC, President, Chief Executive Officer & Director at AMAG Pharmaceuticals, Inc. and Senior Vice President-Marketing for DOV Pharmaceutical, Inc.
Mr. Myers received an undergraduate degree from Northwestern University and an MBA from Graduate School of Business.